A clinical trial to study the effect of drug NANNARI VER OORAL KUDINEER in VALI AZHAL KEEL VAYU( Rheumatoid arthritis)
Phase 2
- Conditions
- Health Condition 1: null- VALI AZHAL KEEL VAY
- Registration Number
- CTRI/2018/06/014450
- Lead Sponsor
- Principal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Symmetrical joint involvement Arthritis of 3 or more joints Florid morning stiffness and swelling that lasts for few hours or days Pain joints swelling especially in the interphalangeal joints Pain criteria score should be greater than or equal to 6
Exclusion Criteria
Age below 18 and above 50 years Gouty arthritis Psoriatic arthritis Mixed connective tissue disorders SLE Extra pulmonary tuberculosis Other auto immune disease Chronic kidney disease Pregnant women and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Therapeutic efficacy of trial drug nannari ver ooral kudineer in vali azhal keel vayuTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Evaluation of siddha diagnostic parameters safety of trial drug pharmacological and Biochemical analysis of trial drugTimepoint: 30 days